Thomas Metcalfe
Tom Metcalfe is Head of PHC Healthcare System Partnerships in Roche’s Product Development Medical Affairs organization. He leads activities related to PHC healthcare partnerships, clinical decision support, value based healthcare and outcomes innovation within Roche Pharma’s global medical affairs organization. Prior to this Tom was the Data Policy Lead within the Roche Pharma Personalised Healthcare (PHC) Centre of Excellence until March 2019. Between March 2015 and March 2018 he was a Strategic Innovation Leader in Roche Pharma Global Product Development with a focus on Digital Health, Innovative Development Pathways and the use of comprehensive genomics profiling technologies in the development of cancer medicines. He joined Roche from Oncotest GmbH, a preclinical CRO focused on oncology models, where he was Managing Director.
Before this Tom spent 7 years working for Roche Pharma as the Global Head of the Biomarker Program (2004-7) and Head of the PHC Portfolio (2007-10). He also spent 10 years working for Roche Diagnostics in a variety of leadership roles in marketing and business development.
Between 2009 and 2011 Tom was chair of the EBE Task Force on Personalised Medicines and currently serves as the Roche Pharma delegate to the European Federation of Pharmaceutical Industry Associations (EFPIA) Innovation Committee.
Tom studied Biochemistry at King's College, London University and has an MBA from the Open University, UK.
Before this Tom spent 7 years working for Roche Pharma as the Global Head of the Biomarker Program (2004-7) and Head of the PHC Portfolio (2007-10). He also spent 10 years working for Roche Diagnostics in a variety of leadership roles in marketing and business development.
Between 2009 and 2011 Tom was chair of the EBE Task Force on Personalised Medicines and currently serves as the Roche Pharma delegate to the European Federation of Pharmaceutical Industry Associations (EFPIA) Innovation Committee.
Tom studied Biochemistry at King's College, London University and has an MBA from the Open University, UK.
Sign in to Autumn ITAPA 2024
-
Value Based Healthcare: a patient centric strategy for better outcomes and sustainable healthcare delivery